Search

everythinglearnresearchcommunity

for

Search:↓

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Finasteride effectively treats male hair loss, improving growth and density.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

Hair follicles are valuable for regenerative medicine and wound healing.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Sensitive skin often causes discomfort, affects many people, especially women and older adults, and should be managed with careful product selection.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

A new hair treatment with caffeine and other ingredients makes hair thicker and less likely to break.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Natural products can help overcome cancer drug resistance.

Senescent melanocytes can boost hair growth by activating hair stem cells.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

South American camelids should be sheared early, fleece type affects fiber quality, and the S/P follicle ratio doesn't distinguish between Bolivian llama genotypes.